硫素对皮症的治疗潜力:来自小鼠模型和临床数据的见解
Meehee Park1, Seungju Cho1, Seonggyu Choi1
1Mitos Biomedical Institute, Mitos Therapeutics Inc., Daejeon, Republic of Korea.
Experimental gerontology
|September 3, 2025
概括
一种炎症性肠病药物sulfasalazine通过抑制肌肉损失在治疗肉症方面表现有前途. 这项研究发现,它改善了动物模型和患者的肌肉力量和质量.
科学领域:
- 生物医学
- 药理学
- 肌肉生物学
背景情况:
- 标志着肌肉质量的逐渐减少,导致残疾和生活质量的降低,治疗选择有限.
- 通过PHF20增强的YY1转录活性抑制肌肉分化,导致肉.
- 现有的治疗方法不足,需要新的治疗策略.
研究的目的:
- 为了选FDA批准的药物,
- 研究硫素在抑制PHF20诱导的YY1促进剂活性方面的疗效.
- 在临床前和临床环境中评估硫素对肌肉质量,强度和功能的影响.
主要方法:
- 在C2C12神经细胞中使用PHF20-YY1促进剂检测以选药物库.
- 对YY1促进剂活性进行抑制度 (IC50) 的评估.
- 在小鼠模型中评估硫素对肌肉强度,功能和质量的影响,并分析了IBD患者的临床数据.
主要成果:
- 硫素显著抑制了PHF20诱导的YY1促进剂活性 (IC50=24μM).
- 治疗降低了YY1表达,并提高了肌肉特异性基因表达.
- 硫素改善了肌肉强度和功能,减轻了小鼠的肌肉损失,IBD患者的总psoas指数更高.
结论:
- 硫素有效抑制了与皮症有关的关键途径.
- 这种药物有潜力作为治疗的药物.
- 对于与炎症性肠病相关的肉症来说,硫萨拉可能特别有益.
相关概念视频
Sulfur Assimilation
511
Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to...
511
Staphylococcal Skin Infections
89
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
89


